Philip Morris Misr Announces Price Increase for its Products

 

Philip Morris Misr Announces Price Increase for its Products

Philip Morris Misr announces new prices for all variants of its heated tobacco products ‘HEETS’ and conventional cigarettes ‘Merit, Marlboro and L&M’.

“For a while, we have been able to absorb the impact of the dynamic economic landscape on prices of raw materials and manufacturing cost. Now, this price increase comes as a necessity to continue securing our ability to provide Egyptian adult smokers and nicotine users with the premium quality products they seek” stated Ali N. Karaman, Egypt & Levant Managing Director.

Philip Morris Misr assures all its adult smokers and nicotine users that the new prices are transparently announced on product packaging through the QR code that was implemented on conventional cigarettes and heated tobacco packs since 2022. The company calls upon retailers and distributors to conform to the declared prices.

Philip Morris Misr’s new price list is as follows:

All variants of Merit will be sold officially at EGP 59 per pack.

All variants of Marlboro will be sold officially at EGP 54 per pack.

All variants of Marlboro Crafted will be sold officially at EGP 44 per pack.

All variants of L&M will be sold officially at EGP 39 per pack.

All variants of HEETS Selections will be sold officially at EGP 48 per pack.

All variants of HEETS Dimensions will be sold officially at EGP 50 per pack.

Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products, including heat not-burn, vapor, and oral nicotine products. Since 2008, PMI has invested more than USD 10.5 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of world-class scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. In November 2022, PMI acquired Swedish Match – a leader in oral nicotine delivery – creating a global smoke-free champion led by the companies’ IQOS and ZYN brands. The U.S. Food and Drug Administration (FDA) has authorized versions of PMI’s IQOS Platform 1 devices and consumables and Swedish Match’s General snus as Modified Risk Tobacco Products (MRTPs). As of December 31, 2022, PMI's smoke-free products were available for sale in 73 markets, and PMI estimates that approximately 17.8 million adults around the world had already switched to IQOS and stopped smoking. Smoke-free products accounted for approximately 32% of PMI’s total full-year 2022 net revenues. With a strong foundation and significant expertise in life sciences, PMI announced in February 2021 its ambition to expand into wellness and healthcare areas and, through its Vectura Fertin Pharma subsidiary, aims to enhance life through the delivery of seamless health experiences.